This investigation is an outgrowth and extension of an earlier UW-GCRC project (88-230-03A1), """"""""Oxyradical Stress Markers During Onset/Resolution of Bronchopulmonary Dysplasia (BPD)."""""""" This investigation will ascertain if inhaled beclomethasone administered in a tapering dose schedule over the first twelve days of life will reduce the incidence and severity of BPD concomitant with a reduction in markers of bronchoalveolar inflammation.
Showing the most recent 10 out of 459 publications